The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia
NCT ID: NCT01708668
Last Updated: 2015-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
12000 participants
INTERVENTIONAL
2012-10-31
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes
NCT02008591
The Effects of Combined Spinal Epidurals on Fever During Labor of First-Time Mothers
NCT00802646
Combined Implementation of Dural Puncture Epidural and Programmed Intermittent Epidural Bolus for Labor Analgesia
NCT03366935
A Comparison of Epidural Analgesia: Continuous Infusion Versus Programmed Intermittent Boluses
NCT02510287
Compared Efficacy of Patient-controlled Epidural Analgesia With or Without Automatic Boluses
NCT03407209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Epidural analgesia (EA) with continuous epidural infusion(CEI)
Epidural analgesia
Continuous epidural infusion
2
Combined spinal-epidural analgesia (CSEA) with continuous epidural infusion(CEI)
Combined spinal-epidural analgesia
Continuous epidural infusion
3
Epidural analgesia (EA) with intermittent epidural bolus (IEB, 2.5 mL bolused every 15 minutes)
Epidural analgesia
Intermittent epidural bolus
4
Epidural analgesia (EA) with intermittent epidural bolus (IEB, 5ml bolused every 30 minutes)
Epidural analgesia
Intermittent epidural bolus
5
Epidural analgesia (EA) with intermittent epidural bolus (IEB, 10ml bolused every 60 minutes)
Epidural analgesia
Intermittent epidural bolus
6
Combined spinal-epidural analgesia (CSEA) with intermittent epidural bolus (IEB, 2.5 mL bolused every 15 minutes)
Combined spinal-epidural analgesia
Intermittent epidural bolus
7
Combined spinal-epidural analgesia (CSEA) with intermittent epidural bolus (IEB, 5ml bolused every 30 minutes)
Combined spinal-epidural analgesia
Intermittent epidural bolus
8
Combined spinal-epidural analgesia (CSEA) with intermittent epidural bolus (IEB, 10ml bolused every 60 minutes)
Combined spinal-epidural analgesia
Intermittent epidural bolus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Epidural analgesia
Combined spinal-epidural analgesia
Continuous epidural infusion
Intermittent epidural bolus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Required labor analgesia
* Chinese
* Spontaneous labor
Exclusion Criteria
* Allergic to opioids and/or local anesthetics
* Failed to performing epidural catheterization
* Organic dysfunction
* Those who were not willing to or could not finish the whole study at any time
* Using or used in the past 14 days of the monoamine oxidase inhibitors
* Alcohol addictive or narcotic dependent patients
* Subjects with a nonvertex presentation or scheduled induction of labor
* Twin gestation and breech presentation
20 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ShanWu Feng, M.D.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ShanWu Feng, M.D.
Department of Anesthesiology, Nanjing Maternal and Child Health Care Hospital, Nanjing, Jiangsu, China, 210004
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shanwu Feng, M.D.
Role: STUDY_DIRECTOR
Nanjing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanjing Maternal and Child Health Care Hospital Affiliated to Nanjing Medical University
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08NMUM063
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
YKK08119
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
YKK11058
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
NJMCHH-2012-A010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.